Gout Therapeutics Industry Global Research and Analysis 2020 Oct-2016

Global Gout Therapeutics Market 2016-2020

Global Gout Therapeutics Market 2016-2020 is the latest addition to Sandlerresearch.org industry
research reports collection.
Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main
symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it
is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering
agents are preferred treatment options for gout.
The analysts forecast Global Gout Therapeutics Market to grow at a CAGR of 17.16% during the period
2016-2020.
Covered in this Report
This report covers the present scenario and the growth prospects of the global Gout Therapeutics
Market for 2016-2020.
Inquire for more information @ http://www.sandlerresearch.org/inquire-beforebuying?rname=62095
Key vendors
AstraZeneca
Horizon Pharma
Takeda Pharmaceuticals
Other prominent vendors
Ablynx
Alder Biopharmaceuticals
Antares Pharma
Astellas Pharma
Boehringer Ingelheim
Can-Fite BioPharma
Celgene
Celltrion
ChemoCentryx
CymaBay Therapeutics
Eisai
Eli Lilly
Gilead Sciences